Trademarkia Logo

Canada

C$
Trademark Search in Canada
MYFEMBREE Logo

View On IC.GC.CA

MYFEMBREE Logo
APPROVED

on 27 May 2025

Last Applicant/ Owned by

Sumitomo Pharma Switzerland GmbH

Aeschengraben 27,4051 Basel

CH

Serial Number

2093763 filed on 22nd Mar 2021

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

CA

K1P1C3

MYFEMBREE Logo

Trademark usage description

pharmaceutical preparations for human use for use in oncology, endocrinology, and in treatment of hormone related diseases and conditions and in treat Read More

Vienna Information

2 . 9 . 1

Hearts -- Note: Including also hearts represented as a symbol or on playing cards.Coeurs -- Note: Y compris les coeurs représentés comme symboles ou figurant sur des jeux de cartes.

1 . 15 . 15

DropsGouttes

Classification Information

Class [005]
Pharmaceutical preparations for human use for use in oncology, endocrinology, and in treatment of hormone related diseases and conditions and in treatment of women's health issues, namely, infertility, uterine fibroids and symptoms thereof, endometriosis and symptoms thereof, and symptoms of menopause; biologic preparations made from living tissues for medical and therapeutic purposes, for use in oncology, endocrinology, and in treatment of hormone related diseases and conditions and in treatment of women's health issues, namely, infertility, uterine fibroids and symptoms thereof, endometriosis and symptoms thereof, and symptoms of menopause

Classification kind code

11

Class [044]
Providing health and medical information in the fields of women's health, fertility treatments, pharmaceutical advice in the nature of information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals, medical treatment services, and disease management in the fields of oncology, endocrinology, and in treatment of hormone related diseases and conditions and in treatment of women's health issues, namely, infertility, uterine fibroids and symptoms thereof, endometriosis and symptoms thereof, and symptoms of menopause; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions.

Classification kind code

11

Mark Details

Serial Number

2093763

Mark Type

Trademark

Legal History

Action TakenStatus
Submitted for opposition 26
on 27th May 2025		Approved
Submitted for opposition 27
on 27th May 2025		Approval Notice Sent
Submitted for opposition 15
on 14th Nov 2024		Correspondence Created
Submitted for opposition 135
on 16th Jul 2024		Amendment to Application
Submitted for opposition 22
on 19th Mar 2024		Search Recorded
Submitted for opposition 20
on 19th Mar 2024		Examiner's First Report
Submitted for opposition 287
on 29th Jun 2022		Pre-Assessment Letter Sent
Submitted for opposition 30
on 22nd Mar 2021		Filed
Submitted for opposition 1
on 22nd Mar 2021		Created
Submitted for opposition 31
on 22nd Mar 2021		Formalized